A Clinical Framework for Assessing Cannabis Impairment Risk in Patients
Researchers developed a practical framework for clinicians to assess and stratify cannabis-related impairment risk, especially for patients performing safety-sensitive work duties.
Quick Facts
What This Study Found
The framework provides clinicians with a structured approach to evaluate impairment-related factors in medical cannabis patients, including dosing, tolerance, timing, and individual risk factors. It is designed for patients performing safety-sensitive duties and can inform workplace assessments.
Key Numbers
Framework designed for all patients performing safety-sensitive duties; applicable to current users and those considering medical cannabis
How They Did This
Clinical framework development based on review of existing evidence on cannabis-related neurocognitive impairment, intended as a practical tool for healthcare providers managing medical cannabis patients.
Why This Research Matters
As medical cannabis use grows, clinicians lack practical tools to evaluate impairment risk. This framework fills a gap between prescribing cannabis and ensuring patients can safely work and drive.
The Bigger Picture
The tension between medical cannabis access and workplace/road safety demands practical solutions. Clinical impairment risk assessment could help patients maintain employment while using medical cannabis safely.
What This Study Doesn't Tell Us
Framework is expert-developed rather than validated in clinical trials. Individual impairment varies widely and may be difficult to predict from any standardized assessment.
Questions This Raises
- ?How accurately can clinicians predict impairment risk using this framework?
- ?Would employers accept clinician-assessed impairment risk as sufficient for safety-sensitive positions?
Trust & Context
- Key Stat:
- Designed for safety-sensitive duty assessment
- Evidence Grade:
- Expert-developed framework based on existing evidence, not yet validated in clinical practice.
- Study Age:
- Published in 2022
- Original Title:
- A Clinical Framework for Assessing Cannabis-Related Impairment Risk.
- Published In:
- Frontiers in psychiatry, 13, 883517 (2022)
- Authors:
- MacCallum, Caroline A(5), Lo, Lindsay A(5), Pistawka, Carly A(2), Christiansen, April, Boivin, Michael, Snider-Adler, Melissa
- Database ID:
- RTHC-04024
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
How do doctors assess cannabis impairment risk?
This framework provides a structured approach for clinicians to evaluate factors like dosing, tolerance, timing, and individual risk factors to stratify a patient's impairment risk level.
Can medical cannabis patients work in safety-sensitive jobs?
The framework is designed to help clinicians make that determination by assessing impairment risk factors specific to each patient, rather than applying a blanket prohibition.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
- employer-drug-test-thc-2026
- cannabis-security-clearances-federal-government
- thc-and-exercise-working-out-high
- using-cannabis-at-work-risks-rights-science
Cite This Study
https://rethinkthc.com/research/RTHC-04024APA
MacCallum, Caroline A; Lo, Lindsay A; Pistawka, Carly A; Christiansen, April; Boivin, Michael; Snider-Adler, Melissa. (2022). A Clinical Framework for Assessing Cannabis-Related Impairment Risk.. Frontiers in psychiatry, 13, 883517. https://doi.org/10.3389/fpsyt.2022.883517
MLA
MacCallum, Caroline A, et al. "A Clinical Framework for Assessing Cannabis-Related Impairment Risk.." Frontiers in psychiatry, 2022. https://doi.org/10.3389/fpsyt.2022.883517
RethinkTHC
RethinkTHC Research Database. "A Clinical Framework for Assessing Cannabis-Related Impairme..." RTHC-04024. Retrieved from https://rethinkthc.com/research/maccallum-2022-a-clinical-framework-for
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.